Trials / Completed
CompletedNCT07506213
Development, Feasibility and Acceptability of Recipes for Locally Available, Specially Formulated Foods for the Management of Moderate Acute Malnutrition in Niger (Related to NCT06382857 Protocol)
Development, Feasibility and Acceptability of Recipes for Locally Available, Specially Formulated Foods for the Management of Moderate Acute Malnutrition in Niger: a Randomized Crossover Feeding Study With Home-use Evaluation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Epicentre · Academic / Other
- Sex
- All
- Age
- 6 Months – 23 Months
- Healthy volunteers
- Not accepted
Summary
The study consisted of two phases. Phase 1 was a recipe development phase, which aimed to identify recipes that meet ≥80% of the recommended nutrient profile for Specially Formulated Foods (SFF) used in the standard management of MAM and made with locally available ingredients. In Phase 2, the recipes developed during Phase 1 were evaluated for acceptability among children 6 to \< 24 months of age with MAM during a randomized crossover feeding study with a 30-minute observed test dose and evaluation of at-home use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Locally Available Food | Phase 1 of the present study developed supplementary food recipes using locally available, non-perishable ingredients. Market surveys identified 49 foods, reduced to 30 suitable items. Using linear programming in the Cost of the Diet software, 24 recipes meeting ≥80% of the nutrient profile for standard MAM treatment were generated, each including 2 g of micronutrient powder. A 2022 market survey in Maradi assessed prices and year-round availability; only six recipes met this requirement and were selected. A standardized method for at-home preparation of each recipe was developed. |
Timeline
- Start date
- 2022-08-19
- Primary completion
- 2022-11-11
- Completion
- 2022-11-11
- First posted
- 2026-04-01
- Last updated
- 2026-04-07
Locations
1 site across 1 country: Niger
Source: ClinicalTrials.gov record NCT07506213. Inclusion in this directory is not an endorsement.